SEC Form 4 · accession 0001140361-18-032190
CASTLIGHT HEALTH, INC. · CSLT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Seth B. Cohen
Director
Period of report
Jul 9, 2018
Accepted (ET)
Jul 11, 2018 · 5:55 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001433714
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Class B Common Stock | Jul 9, 2018 | S | 3,290 | $4.50 | D | 322,226 | D | |
| Class B Common Stock | Jul 9, 2018 | S | 200 | $4.525 | D | 322,026 | D | |
| Class B Common Stock | Jul 10, 2018 | S | 1,400 | $4.50 | D | 320,626 | D | |
| Class B Common StockF2,F3 | Jul 11, 2018 | S | 5,110 | $4.5088 | D | 315,516 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1This transaction was effected pursuant to a 10b5-1 trading plan previously adopted by the Reporting Person.
- F2Represents the aggregate of sales effected on the same day at different prices.
- F3Represents the weighted average sales price per share. The shares sold at prices ranging from $4.50 to $4.55 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.